From Chronic Back Pain to Black Diamond Runs: Dr. Jason M. Cuellar Restores Motion with Three-Level Lumbar Disc Replacement for Endoscopic Spine Pioneer Dr. Scott Adelman

Spine Surgeon Returns to Competitive Sports, Completes a Triathlon Just 8 Months After Successful Motion-Preserving Spine Surgery PALM BEACH, FL / ACCESS Newswire / July 7, 2025 / When Dr. Scott Adelman, a nationally recognized leader in endoscopic spine surgery and interventional pain management, began experiencing debilitating low back pain, he understood better than most […]

SAREPTA THERAPEUTICS, INC. (NASDAQ: SRPT) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Sarepta Therapeutics, Inc. Investors of Upcoming Deadline

(NASDAQ:SRPT), NEW YORK, July 07, 2025 (GLOBE NEWSWIRE) — Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds Sarepta Therapeutics, Inc. (“Sarepta” or the “Company”) (NASDAQ: SRPT) investors of an upcoming deadline involving a securities fraud class action lawsuit commenced against the Company. Should You Join This Class Action Lawsuit? Do you, or

SAREPTA THERAPEUTICS, INC. (NASDAQ: SRPT) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Sarepta Therapeutics, Inc. Investors of Upcoming Deadline

SAREPTA THERAPEUTICS, INC. (NASDAQ: SRPT) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Sarepta Therapeutics, Inc. Investors of Upcoming Deadline GlobeNewswire July 07, 2025 NEW YORK, July 07, 2025 (GLOBE NEWSWIRE) — Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds Sarepta Therapeutics, Inc. (“Sarepta” or the “Company”) (NASDAQ: SRPT) investors of an upcoming deadline

Get Your Glow On: SkinSeoul Announces Epic K-Beauty Deal Event July 4 – July 7

Seoul, South Korea , July 07, 2025 (GLOBE NEWSWIRE) — As Amazon Prime Day approaches, SkinSeoul is launching its own bold counter-event, The Great Glow Up 2025, featuring even lower prices on top-rated Korean skincare products — with a guarantee to match Amazon's prices. The AI-powered Korean beauty startup is rapidly establishing itself as the

APPLE INC. (NASDAQ: AAPL) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Apple Inc. Investors of Upcoming Deadline

(NASDAQ:AAPL), NEW YORK, July 07, 2025 (GLOBE NEWSWIRE) — Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds Apple Inc. (“Apple” or the “Company”) (NASDAQ: AAPL) investors of an upcoming deadline involving a securities fraud class action lawsuit commenced against the Company. Should You Join This Class Action Lawsuit? Do you, or did

Get Your Glow On: SkinSeoul Announces Epic K-Beauty Deal Event July 4 – July 7

Get Your Glow On: SkinSeoul Announces Epic K-Beauty Deal Event July 4 – July 7 GlobeNewswire July 07, 2025 Seoul, South Korea , July 07, 2025 (GLOBE NEWSWIRE) — As Amazon Prime Day approaches, SkinSeoul is launching its own bold counter-event, The Great Glow Up 2025, featuring even lower prices on top-rated Korean skincare products

APPLE INC. (NASDAQ: AAPL) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Apple Inc. Investors of Upcoming Deadline

APPLE INC. (NASDAQ: AAPL) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Apple Inc. Investors of Upcoming Deadline GlobeNewswire July 07, 2025 NEW YORK, July 07, 2025 (GLOBE NEWSWIRE) — Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds Apple Inc. (“Apple” or the “Company”) (NASDAQ: AAPL) investors of an upcoming deadline involving a securities

Orsini Selected as Specialty Pharmacy Partner for KalVista’s EKTERLY® (sebetralstat)

EKTERLY is an FDA-approved oral therapy for the on-demand treatment of hereditary angioedema (HAE) Orsini, a leader in rare disease pharmacy solutions, has been chosen by KalVista Pharmaceuticals as a specialty pharmacy partner for EKTERLY® (sepiapterin), an FDA-approved oral therapy for the treatment of acute attacks of hereditary angioedema (HAE) in adult and pediatric patients

TEMPUS AI, INC. (NASDAQ: TEM) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Tempus AI, Inc. Investors of Upcoming Deadline

(NASDAQ:TEM), NEW YORK, July 07, 2025 (GLOBE NEWSWIRE) — Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds Tempus AI, Inc. (“Tempus” or the “Company”) (NASDAQ: TEM) investors of an upcoming deadline involving a securities fraud class action lawsuit commenced against the Company. Should You Join This Class Action Lawsuit? Do you, or

Scroll to Top